CID 118557502

Gsk3145095

Structural Information

Molecular Formula
C20H17F2N5O2
SMILES
C1CC2=C(C(=CC(=C2)F)F)NC(=O)[C@H]1NC(=O)C3=NNC(=N3)CC4=CC=CC=C4
InChI
InChI=1S/C20H17F2N5O2/c21-13-9-12-6-7-15(19(28)25-17(12)14(22)10-13)23-20(29)18-24-16(26-27-18)8-11-4-2-1-3-5-11/h1-5,9-10,15H,6-8H2,(H,23,29)(H,25,28)(H,24,26,27)/t15-/m0/s1
InChIKey
ATQAGKAMBISZQM-HNNXBMFYSA-N
Compound name
5-benzyl-N-[(3S)-7,9-difluoro-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

2
References

75
Patents

397.13504 Da
Monoisotopic Mass

3.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 398.14232 191.6
[M+Na]+ 420.12426 198.6
[M-H]- 396.12776 194.1
[M+NH4]+ 415.16886 197.9
[M+K]+ 436.09820 194.9
[M+H-H2O]+ 380.13230 178.3
[M+HCOO]- 442.13324 203.3
[M+CH3COO]- 456.14889 198.3
[M+Na-2H]- 418.10971 191.0
[M]+ 397.13449 183.2
[M]- 397.13559 183.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe